Controlling aging with drugs is a remarkable idea, and some might say an outlandish one. But two Massachusetts scientists say they're enticingly close to making the idea a reality.
The brains behind the idea are Harvard Medical School scientist David Sinclair, 38, and millionaire investor Christoph Westphal, the 39-year-old CEO of Sirtris Pharmaceuticals.
They say they hope the research they're doing in Cambridge, Mass., the biotech hub of the universe, will revolutionize medicine.
"If we...Full Story